(2023)
Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data.
BMC GASTROENTEROLOGY.
23,
1
(2023)
Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-Analysis.
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
82,
3
(2023)
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma.
JHEP REPORTS.
5,
9
(2023)
Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study.
PLOS ONE.
18,
7
(2023)
KASL clinical practice guidelines for management of autoimmune hepatitis 2022.
CLINICAL AND MOLECULAR HEPATOLOGY.
29,
3
(2023)
Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY.
21,
7
(2023)
Transarterial radioembolization versus tyrosine ki- nase inhibitor in hepatocellular carcinoma with portal vein thrombosis.
CLINICAL AND MOLECULAR HEPATOLOGY.
29,
3
(2023)
Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B.
WORLD JOURNAL OF GASTROENTEROLOGY.
29,
24
(2023)
Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B.
SCIENTIFIC REPORTS.
13,
1
(2023)
Rescue therapy for local tumor progression after radiofrequency ablation of small hepatocellular carcinoma: a comparison between repeated ablation and transcatheter arterial chemoembolization.
BRITISH JOURNAL OF RADIOLOGY.
96,
1146
(2023)
Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study.
CANCERS.
15,
11
(2023)
Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis.
HEPATOLOGY.
77,
5
(2023)
Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients' Returning to Work (START): A Multi-center, Randomized Controlled Trial.
CANCER RESEARCH AND TREATMENT.
55,
2
(2023)
Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY.
35,
4
(2022)
Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study.
HEPATOLOGY.
76,
6
(2022)
Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea.
KOREAN JOURNAL OF INTERNAL MEDICINE.
37,
5
(2022)
Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
DIGESTIVE DISEASES AND SCIENCES.
67,
9
(2022)
Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection.
JOURNAL OF NUCLEAR MEDICINE.
63,
8
(2022)
Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017.
FRONTIERS IN ONCOLOGY.
12,
-
(2022)
Second-line Sonazoid-enhanced ultrasonography for Liver Imaging Reporting and Data System category 3 and 4 on gadoxetate-enhanced magnetic resonance imaging.
ULTRASONOGRAPHY.
41,
3
학술회의논문
(2019)
Factors associated with rapid progressive disease despite transarterial chemoembolization in intermediate stage hepatocellular carcinoma: Potential implications for treatment selection.
KDDW2019.
대한민국
(2019)
Predictors and outcome of emergent liver transplantation for patients with acute-on-chronic liver failure.
KDDW2019.
대한민국
